LabCorp CRU, Inc.

Madison, Wisconsin 53704

0 studies enrolling now · 8 studies all time

What they study most

Healthy, Obese

Studies at this site

• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants — Completed
• A Study of [¹⁴C]-LY3484356 in Healthy Female Participants — Completed
• A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants — Completed
• A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants — Completed
• A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants — Completed
• A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants — Completed
• A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants — Completed